Condition
Recurrent Glioma clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Recurrent Glioma clinical trials that are recruiting, at sites in 2 countries (most in United States (4), China (1)). By phase: Phase 1 (3). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 2Countries
Newest Recurrent Glioma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Sitagliptin plus bevacizumab for recurrent grade 4 glioma | Phase 1 | Iowa City, Iowa | Recruiting | Apr 21, 2026 |
| Home-based digital platform delivering sequential therapy for people with glioma | — | Jacksonville, Florida and 1 other locations | Recruiting | Jul 20, 2025 |
| Proton pulsed reduced-dose-rate radiotherapy for recurrent high-grade glioma | — | Boca Raton, Florida and 1 other locations | Recruiting | May 3, 2024 |
| Using CARv3-TEAM-E T Cells to treat glioblastoma | Phase 1 | Boston, Massachusetts | Recruiting | Dec 21, 2022 |
| Testing GNC-039 in patients with advanced solid tumors | Phase 1 | Beijing, Beijing Municipality and 5 other locations | Recruiting | Mar 12, 2021 |
All recruiting trials (5)
-
Sitagliptin plus bevacizumab for recurrent grade 4 glioma
This study tests whether adding sitagliptin to bevacizumab can help people whose recurrent glioblastoma or other grade 4 gliomas respond to treatment and to find a safe dose when used with bevacizumab.
-
Home-based digital platform delivering sequential therapy for people with glioma
This program will test a mobile app that helps deliver and remotely monitor home-based systemic therapy for adults with newly diagnosed or recurrent glioma.
-
Proton pulsed reduced-dose-rate radiotherapy for recurrent high-grade glioma
This trial tests whether a special proton radiation method called PRDR helps people whose fast-growing glioma has come back after prior radiation.
-
Using CARv3-TEAM-E T Cells to treat glioblastoma
This study is testing the best dose of a new type of immune cell treatment for people with glioblastoma, a serious brain cancer, to see how safe and effective it is.
-
Testing GNC-039 in patients with advanced solid tumors
This study is testing a new treatment called GNC-039 to see if it is safe and effective for people with advanced solid tumors, including those with relapsed or hard-to-treat gliomas.
Related topics
Quick answers
How many Recurrent Glioma clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (4 trials), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 3. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.